EMEA-003646-PIP01-24 - paediatric investigation plan
plinabulin
PIP
Human
Key facts
- Active substance
- plinabulin
- Therapeutic area
- Neoplasms benign, malignant and unspecified (incl cysts and polyps)
- Decision number
- P/0368/2024
- PIP number
- EMEA-003646-PIP01-24
- Pharmaceutical form(s)
- All pharmaceutical forms
- Condition(s) / indication(s)
- Treatment of lung carcinoma (small cell and non-small cell carcinoma)
- Route(s) of administration
- All routes of administration
- Contact for public enquiries
Beyondspring Pharmaceuticals Inc.
E-mail: claire.li@beyondspringpharma.com
Tel.: +1 4016880172- Decision type
- W: decision granting a waiver in all age groups for all conditions or indications
- Decision date
- Compliance check done
- No